MedTrace Logo

Contextualizing the Evidence for Action on Diabetes - Cohort

NCT04560062 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1152

Last updated 2021-01-25

No results posted yet for this study

Summary

This protocol reflects the second part of a larger mixed-methods study aimed at exploring the process by which global recommendations can be translated into context-specific, evidence-informed action for diabetes prevention in low-resource settings. Firstly, a retrospective cohort study will assess the current level of implementation of comprehensive diabetes care over a 24-month period (2019-2020), by describing healthcare received and health outcomes of a representative sample of diabetes patients currently accessing care in the study region. Focus groups prompted by the findings of the retrospective study will be used to inspire local innovations which will be evaluated through a prospective follow-up of the cohort.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

OTHER

Spontaneous changes in diabetes-related health care

The findings of a retrospective cohort analysis conducted in the initial phase of the study will be used in focus groups to identify observed weaknesses in local health systems and will promote possible solutions to strengthen diabetes-related health care. Every focus group will include community members, healthcare workers, decision-makers and diabetic patients and family members.

Sponsors & Collaborators

  • European Research Council

    collaborator OTHER

  • Pontificia Universidad Católica del Ecuador

    collaborator UNKNOWN

  • Centro de Epidemiología Comunitaria y Medicina Tropical

    collaborator UNKNOWN

  • Universidad Miguel Hernandez de Elche

    lead OTHER

Principal Investigators

  • Lucy A Parker, PhD · University Miguel Hernández

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-13
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Ecuador

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04560062 on ClinicalTrials.gov